These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17376429

  • 1. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
    Pogocki D, Ruman T, Danilczuk M, Danilczuk M, Celuch M, Wałajtys-Rode E.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):18-39. PubMed ID: 17376429
    [Abstract] [Full Text] [Related]

  • 2. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug 01; 28(4):149-58. PubMed ID: 18800618
    [Abstract] [Full Text] [Related]

  • 3. Nicotine and brain disorders.
    Mihailescu S, Drucker-Colín R.
    Acta Pharmacol Sin; 2000 Feb 01; 21(2):97-104. PubMed ID: 11263271
    [Abstract] [Full Text] [Related]

  • 4. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC, Bertrand D.
    Biochem Pharmacol; 2007 Feb 15; 73(4):459-68. PubMed ID: 16979139
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolism and biochemical effects of nicotine for primary care providers.
    Metz CN, Gregersen PK, Malhotra AK.
    Med Clin North Am; 2004 Nov 15; 88(6):1399-413, ix. PubMed ID: 15464104
    [Abstract] [Full Text] [Related]

  • 12. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
    Egleton RD, Brown KC, Dasgupta P.
    Pharmacol Ther; 2009 Feb 15; 121(2):205-23. PubMed ID: 19063919
    [Abstract] [Full Text] [Related]

  • 13. Nicotinic acetylcholine receptors as drug targets.
    Hogg RC, Bertrand D.
    Curr Drug Targets CNS Neurol Disord; 2004 Apr 15; 3(2):123-30. PubMed ID: 15078187
    [Abstract] [Full Text] [Related]

  • 14. Does nicotine have beneficial effects in the treatment of certain diseases?
    Birtwistle J, Hall K.
    Br J Nurs; 2004 Apr 15; 5(19):1195-202. PubMed ID: 9006184
    [Abstract] [Full Text] [Related]

  • 15. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Newhouse PA, Potter A, Levin ED.
    Drugs Aging; 1997 Sep 15; 11(3):206-28. PubMed ID: 9303280
    [Abstract] [Full Text] [Related]

  • 16. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
    Ambrose V, Miller JH, Dickson SJ, Hampton S, Truman P, Lea RA, Fowles J.
    Nicotine Tob Res; 2007 Aug 15; 9(8):793-9. PubMed ID: 17654292
    [Abstract] [Full Text] [Related]

  • 17. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
    Newhouse PA, Kelton M.
    Pharm Acta Helv; 2000 Mar 15; 74(2-3):91-101. PubMed ID: 10812945
    [Abstract] [Full Text] [Related]

  • 18. Nicotine and nicotinic receptors; relevance to Parkinson's disease.
    Quik M, Kulak JM.
    Neurotoxicology; 2002 Oct 15; 23(4-5):581-94. PubMed ID: 12428730
    [Abstract] [Full Text] [Related]

  • 19. Nicotine an efficient tool of the neurobiological research today, the tool of treatment tomorrow?
    Riljak V, Langmeier M.
    Prague Med Rep; 2005 Oct 15; 106(4):329-48. PubMed ID: 16572927
    [Abstract] [Full Text] [Related]

  • 20. Nicotine psychopharmacology: policy and regulatory.
    Henningfield JE, Zeller M.
    Handb Exp Pharmacol; 2009 Oct 15; (192):511-34. PubMed ID: 19184661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.